Barry D. Brooks, M.D., Joins NCODA Executive Council

Article

The National Community Oncology Dispensing Association, Inc. (NCODA) is pleased to announce the addition of Barry D. Brooks, M.D. to their Executive Council. Dr. Brooks joined the Council in April.

The National Community Oncology Dispensing Association, Inc. (NCODA) is pleased to announce the addition of Barry D. Brooks, M.D. to their Executive Council. Dr. Brooks joined the Council in April.

Barry D. Brooks, M.D., is a hematologist and medical oncologist with Texas Oncology and for 17 years has worked as physician-lead on the Drug Contracting committee of US Oncology. He was Chair of P&T from 2011 to 2018 and now serves as Medical Director of Oral Oncolytics for USON. He is the author of many publications and abstracts in the field of oncology. ”Being part of NCODA is a great honor. I believe NCODA will do for oncology dispensing what COA has done for community oncology by improving access to oral oncology drugs for America’s cancer patients and giving patients a voice in Washington,” said Dr. Brooks.

“Dr. Brooks, in addition to being an outstanding medical oncologist, is a dynamic individual who will bring a great deal of insight from a physician’s perspective to our NCODA initiatives,” said Jim Schwartz, NCODA President and Executive Council Chair.

For more information about NCODA’s Executive Council and general updates visit ncoda.org